The NBDG-low cells also retained the capacity to differentiate into leukemia phenotypically similar to that of the original patient leukemia as demonstrated by the expression of common cell surface markers, such as CD10 and CD19 (an example shown in Supplementary Table 3). Here, MME is linked to leukemia.